Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001334549-23-000002

Chief Executive Officer gave up 11,315 shares (to pay taxes)

  • Chief Executive Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzo David J Chief Executive Officer 2023-01-09 Grant or award +60,000 109,285 D
Mazzo David J Chief Executive Officer 2023-01-09 Shares withheld for taxes −7,845 $3.00 $23,535 101,440 D
Mazzo David J Chief Executive Officer 2023-01-10 Shares withheld for taxes −3,470 $3.20 $11,087 97,970 D
Derivatives
Mazzo David J Chief Executive Officer 2023-01-09 Grant or award · Stock Options (Right to Buy) +30,000 30,000 D
Loading xslF345X03/wf-form4_167347112819363.xml…